Publication | Open Access
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC
25
Citations
38
References
2021
Year
MedicineReceptor Tyrosine KinasePharmacologyPathologyPharmacotherapyCancer GeneticsOncologyNovel Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1